Hemopexin

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NameHemopexin
Drug Alias NamePlasma derived hemopexin therapy (CSL Behring)CSL-889
ClassificationBiologics > Blood components
Mechanisms of ActionHemopexin replacements
TargetsNot applicable
Therapy Area/IndicationsAnemia, Sickle CellVascular DiseasesST Elevation Myocardial Infarction +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring
Inactive CompaniesCelecor Therapeutics
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsVascular DiseasesST Elevation Myocardial InfarctionMyocardial Infarction +[5] 

Other Information

ATC CodeN/A
Related LinksN/A